Table 3:

Univariate logistic regression analysis for LAMC2 as a predictive biomarker for therapeutic response in PDAC patients

Characteristics	OR	95% CI	P-value
Age (≥65 vs. <65)	1.89	0.55 – 6.57	0.31
Gender (Female vs. Male)	2.26	0.71 – 7.19	0.17
Primary tumor location (Head vs. Other)	2.81	0.83 – 9.49	0.10
Locally Advanced vs. Metastatic	1.36	0.30 – 6.20	0.69
CA19-9 (≥37U/mL vs. <37U/mL)	4.56	0.51 – 41.1	0.18
LAMC2 status (High vs. Low)	4.90	1.45 – 16.6	0.01

OR, odds ratio; CI, confidence interval